![Rituximab in the Treatment of Jo1 Antibody–associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response | Semantic Scholar Rituximab in the Treatment of Jo1 Antibody–associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/02b83683ec2de12b09bfd44e7decc5fb71c8dfa3/3-Figure1-1.png)
Rituximab in the Treatment of Jo1 Antibody–associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response | Semantic Scholar
![Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies | Scientific Reports Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-018-36395-z/MediaObjects/41598_2018_36395_Fig3_HTML.png)
Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies | Scientific Reports
![Life | Free Full-Text | Single Nucleotide Polymorphism in the IL17A Gene Is Associated with Interstitial Lung Disease Positive to Anti-Jo1 Antisynthetase Autoantibodies Life | Free Full-Text | Single Nucleotide Polymorphism in the IL17A Gene Is Associated with Interstitial Lung Disease Positive to Anti-Jo1 Antisynthetase Autoantibodies](https://pub.mdpi-res.com/life/life-11-00174/article_deploy/html/images/life-11-00174-ag-550.jpg?1614233052)
Life | Free Full-Text | Single Nucleotide Polymorphism in the IL17A Gene Is Associated with Interstitial Lung Disease Positive to Anti-Jo1 Antisynthetase Autoantibodies
![Frontiers | Description and Analysis of a Novel Subtype of the Anti-Synthetase Syndrome Characterized by Frequent Attacks of Fever and Systemic Inflammation in a Single-Center Cohort Study Frontiers | Description and Analysis of a Novel Subtype of the Anti-Synthetase Syndrome Characterized by Frequent Attacks of Fever and Systemic Inflammation in a Single-Center Cohort Study](https://www.frontiersin.org/files/Articles/729602/fimmu-12-729602-HTML/image_m/fimmu-12-729602-g001.jpg)
Frontiers | Description and Analysis of a Novel Subtype of the Anti-Synthetase Syndrome Characterized by Frequent Attacks of Fever and Systemic Inflammation in a Single-Center Cohort Study
![Identifying Jo-1-Specific B Cells in the Primary Immune Repertoire in Idiopathic Inflammatory Myopathies - ACR Meeting Abstracts Identifying Jo-1-Specific B Cells in the Primary Immune Repertoire in Idiopathic Inflammatory Myopathies - ACR Meeting Abstracts](https://acrabstracts.org/wp-content/uploads/2019/08/GTUOHVCE-699756-1-ANY.png)
Identifying Jo-1-Specific B Cells in the Primary Immune Repertoire in Idiopathic Inflammatory Myopathies - ACR Meeting Abstracts
![StudyXing Medicine on X: "Polymyositis: Autoimmune, inflammatory muscle destruction --> proximal bilateral wkness (shoulders, hips MC), fatigue, inability to rise from sitting; Pos+ anti-Jo-1, anti-SRP, anti-Mi-2 antibodies, high CK; Bx: endomysial ... StudyXing Medicine on X: "Polymyositis: Autoimmune, inflammatory muscle destruction --> proximal bilateral wkness (shoulders, hips MC), fatigue, inability to rise from sitting; Pos+ anti-Jo-1, anti-SRP, anti-Mi-2 antibodies, high CK; Bx: endomysial ...](https://pbs.twimg.com/media/FTOpXDkXwAA_dKG.jpg:large)
StudyXing Medicine on X: "Polymyositis: Autoimmune, inflammatory muscle destruction --> proximal bilateral wkness (shoulders, hips MC), fatigue, inability to rise from sitting; Pos+ anti-Jo-1, anti-SRP, anti-Mi-2 antibodies, high CK; Bx: endomysial ...
![Differences in the Clinical Characteristics and 1-Year Mortality Rates of Patients with Dermatomyositis with anti-Jo-1 and anti-MDA5 Antibodies Differences in the Clinical Characteristics and 1-Year Mortality Rates of Patients with Dermatomyositis with anti-Jo-1 and anti-MDA5 Antibodies](https://static.hindawi.com/articles/jir/volume-2023/2988422/figures/2988422.fig.002.jpg)
Differences in the Clinical Characteristics and 1-Year Mortality Rates of Patients with Dermatomyositis with anti-Jo-1 and anti-MDA5 Antibodies
![SocvenezolanaReumato on X: "El anti-Jo-1 es el Ac anti- sintetasa mas comun y se correlaciona #miositis, enfermedad pulmonar #artritis y mano de mecanico #reumatologia https://t.co/UXlT1v9DUw" / X SocvenezolanaReumato on X: "El anti-Jo-1 es el Ac anti- sintetasa mas comun y se correlaciona #miositis, enfermedad pulmonar #artritis y mano de mecanico #reumatologia https://t.co/UXlT1v9DUw" / X](https://pbs.twimg.com/media/C-SbfRPXsAAY6oS.jpg)
SocvenezolanaReumato on X: "El anti-Jo-1 es el Ac anti- sintetasa mas comun y se correlaciona #miositis, enfermedad pulmonar #artritis y mano de mecanico #reumatologia https://t.co/UXlT1v9DUw" / X
![Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres | Journal of Neurology, Neurosurgery & Psychiatry Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres | Journal of Neurology, Neurosurgery & Psychiatry](https://jnnp.bmj.com/content/jnnp/68/4/472/F4.large.jpg)